It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Pancreatic cancer is characterized by abundant desmoplasia, a dense stroma composed of extra-cellular and cellular components, with cancer associated fibroblasts (CAFs) being the major cellular component. However, the tissue(s) of origin for CAFs remains controversial. Here we determine the tissue origin of pancreatic CAFs through comprehensive lineage tracing studies in mice. We find that the splanchnic mesenchyme, the fetal cell layer surrounding the endoderm from which the pancreatic epithelium originates, gives rise to the majority of resident fibroblasts in the normal pancreas. In a genetic mouse model of pancreatic cancer, resident fibroblasts expand and constitute the bulk of CAFs. Single cell RNA profiling identifies gene expression signatures that are shared among the fetal splanchnic mesenchyme, adult fibroblasts and CAFs, suggesting a persistent transcriptional program underlies splanchnic lineage differentiation. Together, this study defines the phylogeny of the mesenchymal component of the pancreas and provides insights into pancreatic morphogenesis and tumorigenesis.
Cancer-associated fibroblasts (CAFs) are the main component of the stroma in pancreatic cancer, but their tissue of origin remains to be defined. Here the authors perform lineage tracing and single cell RNA sequencing in mice and suggest the splanchnic mesenchyme as the tissue of origin for CAFs.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Medical University of South Carolina, Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Charleston, USA (GRID:grid.259828.c) (ISNI:0000 0001 2189 3475)
2 Medical University of South Carolina, Department of Microbiology and Immunology, Hollings Cancer Center, Charleston, USA (GRID:grid.259828.c) (ISNI:0000 0001 2189 3475); Medical College of Wisconsin, Medical College of Wisconsin Cancer Center, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460)
3 Medical College of Wisconsin, Division of Biostatistics, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460); Medical College of Wisconsin, Medical College of Wisconsin Cancer Center, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460)
4 Medical College of Wisconsin, Medical College of Wisconsin Cancer Center, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460); Medical College of Wisconsin, Department of Biochemistry, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460)
5 Medical College of Wisconsin, Medical College of Wisconsin Cancer Center, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460); Medical College of Wisconsin, Department of Biochemistry, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460); Medical College of Wisconsin, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460); Medical College of Wisconsin, Clinical and Translational Sciences Institute, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460)
6 Medical College of Wisconsin, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460); Medical College of Wisconsin, Department of Surgery, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460)
7 Medical College of Wisconsin, Medical College of Wisconsin Cancer Center, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460); Medical College of Wisconsin, Department of Biochemistry, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460); Medical College of Wisconsin, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460); Medical College of Wisconsin, Department of Surgery, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460)